New Users          



General & Disorder-Specific Ethical & Clinical Considerations

NEW 2018
15 CE Credit Hours - Online Course - $129.00

Developed by Ofer Zur, Ph.D.

Course fulfills the licensing requirement of Psychopharmacology for CA LMFT applicants with out-of-state education.
Check with your state's licensing board.

This course was produced in collaboration between Taylor & Francis, PLC and the Zur Institute, Inc.
The Zur Institute, Inc. maintains responsibility for this continuing education program and its content.

Board Approvals for Psychologists, LMFTs, SWs, Counselors, & Nurses

Simply follow these steps:

1. Sign up securely online.
2. Read articles.

3. Submit evaluation & post-test.
4. Print your certificate.


To order this Course now
Order Course now, click here


General Course Description

PsychopharmacologyAs the trends toward medicalization and medication for mental disorders grow, psychologists, counselors, marriage and family therapists and social workers must expand their knowledge of psychopharmacology. When appropriate, they communicate with prescribing physicians. They also need to educate themselves regarding the pros and cons of using medications and to help clients, when necessary, communicate with their prescribing physicians. It is often helpful for the psychotherapist to communicate directly with the prescribing physician, especially with more vulnerable clients, such as the children, and the seriously mental ill, who are more likely to be over-diagnosed and have their meds inadequately monitored. Psychotherapists can do this effectively only if they, themselves, understand the advantages, pitfalls, interaction effects and other complexities of psychotropic medications.

This 15 CE credit hour intermediate level course consists of three parts. Part One presents shared decision-making models between patients and physicians and presents ethical and clinical guidelines concerning prescribing medications. Part Two discusses recent advances in medications for bipolar disorder, the ongoing controversy over the effectiveness of antidepressants for treating depression and the use of antidepressants for pregnant or lactating women. Part Three discusses ADHD medications for children and adolescents. Additional resources and references are provided for further study, but they are not part of the course.


Educational Objectives

    This course will teach the participant to:
  • Describe the CommonGround model of decision making about medications between physicians and patients
  • Describe a communication-centered epistemic model of shared decision-making between physicians and patients
  • Describe how prescribing patterns with vulnerable populations differ from prescribing patterns with other patients
  • Discuss patients' reactions and concerns about medications
  • Discuss the complex relationship between diagnosis and prescribing medications
  • Discuss whether the effectiveness of antidepressant medications is fundamentally a placebo effect
  • Describe the special considerations when prescribing medications for children and adolescents
  • Evaluate recent developments in medications for bipolar disorder
  • Discuss how antidepressants have altered depressed people's view of their self
  • Discuss considerations about prescribing antidepressants for pregnant or lactating women
  • Discuss the controversies surrounding increased diagnosis of ADHD
  • Describe mothers' views of ADHD medications
  • Describe the concept of the neurochemical self
  • Discuss the mechanisms of ADHD medications
  • Discuss the mechanisms of bipolar and antidepressant medications

Course Syllabus

  • Shared decision-making models between physicians and consumers regarding treatment and medications
    • CommonGround
    • Epistemic model
  • Issues concerning psychotropics for vulnerable populations
  • Over-prescribing
  • Inadequate monitoring
  • Prescribing for children, adolescents, the elderly and seriously mentally ill
  • Emerging medications for bipolar disorder
  • Controversies concerning antidepressants
    • Effectiveness versus placebo
    • Replacing traditional sense of self with neurochemical self
    • Prescribing for pregnant or lactating women
  • Medications for ADHD
    • Do we over-prescribe for ADHD?
    • Is ADHD over-diagnosed?
    • Mothers' views of ADHD medications for their children
    • Comparison of methylphenidate and atomoxetine


To order this Course now
Order Course now, click here


Accommodations for Disabilities                   Clinical Updates Email Sign Up                  Refund & Course Exchange Policies



      Twitter Facebook LinkedIn YouTube

Online CE Courses
CE Board Approvals
58 Essential Clinical Forms
HIPAA Compliance Kit
Private Practice Handbook
Private Practice Resources
Free Online Resources
Organizational Discounts
Site Map

Issues Facing Teenagers
Boundaries & Dual Relationships
About Us
Info for the General Public
ADA Policy & Grievance
Privacy, Disclaimer, Terms of Use, DMCA

© 1995 - 2018 ZUR INSTITUTE, Inc.             Ofer Zur, Ph.D., Director             Contact Zur Institute, Inc.